InvestorsHub Logo

iclight

04/29/22 3:34 PM

#463790 RE: Lykiri #463474

And then Medicenna met with the FDAs prior to designing the trial and the two agreed on a hybrid control.

Wonder why? As if they didn’t ask about a complete historic control arm.